MAPP BIOPHARMACEUTICAL, INC.
SAN DIEGO, California
Total Received
$444.5M
Total Awards
15
State
California
Last Updated
Mar 17, 2026
Yearly Funding Trend
$443.0M24
$1.5M25
Top 15 Awards to MAPP BIOPHARMACEUTICAL, INC.
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 17, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
CONT_AWD_75A50122C00061_7505_-NONE-_-NONE- PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES - TRANSFER GFP TO MAPP CONTACT 21C, EXTEND POP FOR CLIN 0001 & 0006 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2024 | $184,786,391 |
CONT_AWD_75A50122C00076_7505_-NONE-_-NONE- TRANSFER PROPERTY TO HHSO100201600021C. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-50 | 2024 | $110,877,385 |
CONT_AWD_75A50118C00024_7505_-NONE-_-NONE- ADVANCE MBP134, A COCKTAIL OF TWO HUMAN MONOCLONAL ANTIBODIES (MBP047 AND MBP087), AS A POTENTIAL MEDICAL COUNTERMEASURE TO TREAT ACTIVE INFECTIONS OF SUDAN VIRUS - UPDATE INDIREC… | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2024 | $56,704,950 |
CONT_IDV_75A50119D00018_7505 NO COST MODIFICATION TO CHANGE PRIMARY AND SECONDARY COR. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | — | 2024 | $37,511,391 |
CONT_AWD_HHSO100201600021C_7505_-NONE-_-NONE- RECEIVE GOVERNMENT FURNISHED PROPERTY (GFP) FROM MAPP CONTRACTS 75A502122C00061 AND 75A50122C00076 | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2024 | $28,870,288 |
CONT_AWD_75A50120C00198_7505_-NONE-_-NONE- EOI: PRESIDENTIAL COST SAVINGS INITIATIVE (FEBRUARY 26, 2025): EOI NOTICE OF TERMINATION FOR CONVENIENCE | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2024 | $16,413,163 |
CONT_AWD_75A50124C00003_7505_-NONE-_-NONE- NO COST MODIFICATION TO TRANSFER GOVERNMENT FURNISHED PROPERTY UNDER BARDA CONTRACT NO. 75A50122C00076 TO BARDA CONTRACT NO. 75A50124C00003. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | — | SAN DIEGO, CA-51 | 2024 | $2,961,209 |
ASST_NON_R44AI136272_075 DEVELOPMENT OF HIGHLY POTENT HUMAN MONOCLONAL FOR RSV IMMUNO-PROPHYLAXIS - PROJECT SUMMARY RESPIRATORY SYNCYTIAL VIRUS (RSV) IS A LEADING CAUSE OF INFANT HOSPITALIZATIONS IN THE U… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN DIEGO, CA-51 | 2024 | $2,806,262 |
ASST_NON_HDTRA12010010_097 DEOBLIGATION OF EXCESS FUNDS | Department of Defense Defense Contract Management Agency | 12.351 SCIENTIFIC RESEARCH - COMBATING WEAPONS OF MASS DESTRUCTION | SAN DIEGO, CA-51 | 2024 | $1,465,845 |
ASST_NON_SB1AI191871_075 DEVELOPMENT OF HIGHLY POTENT HUMAN MONOCLONAL FOR RSV IMMUNOPROPHYLAXIS - PROJECT SUMMARY GLOBALLY, RESPIRATORY SYNCYTIAL VIRUS (RSV) CAUSES OVER 3 MILLION HOSPITALIZATIONS OF NEO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN DIEGO, CA-51 | 2025 | $993,353 |
CONT_AWD_W81XWH21C0121_9700_-NONE-_-NONE- MACHUPO VIRUS CELL SORTING FOR MONOCLONAL ANTIBODY DISCOVERY | Department of Defense Defense Health Agency | — | FREDERICK, MD-06 | 2024 | $610,839 |
ASST_NON_R44AI192180_075 A NOVEL COST-EFFECTIVE MULTISPECIFIC THERAPEUTIC FOR DENGUE - PROJECT SUMMARY DENGUE REMAINS A MAJOR GLOBAL HEALTH CONCERN FOR WHICH EFFECTIVE PROPHYLACTIC AND THERAPEUTIC OPTIONS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2025 | $294,583 |
CONT_AWD_HT942525F0237_9700_HT942525D0009_9700 ANTIBODY & ANTIGEN SUPPLY | Department of Defense Defense Health Agency | — | SAN DIEGO, CA-51 | 2025 | $110,500 |
CONT_AWD_HT942525FE048_9700_HT942525D0009_9700 HUMAN-DERIVED MONOCLONAL ANTIBODIES AND RECOMBINANT ANTIGENS | Department of Defense Defense Health Agency | — | SAN DIEGO, CA-51 | 2025 | $60,500 |
CONT_IDV_HT942525D0009_9700 MATERIAL REQUIREMENT FOR THE DELIVERY OF ANTIBODY AND ANTIGEN SUPPLY. | Department of Defense Defense Health Agency | — | — | 2025 | $0 |
Top 15 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Industries
View All→12345
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$352.5M
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$56.7M
RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES$28.9M
TESTING LABORATORIES AND SERVICES$611K
IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING$171K
Source: USAspending.gov · All Recipients · California